Article Menu
- Academic Editor
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Tanaka, K.
- Tsuji, K.
- Hiraoka, A.
- Tada, T.
- Hirooka, M.
- Kariyama, K.
- Tani, J.
- Atsukawa, M.
- Takaguchi, K.
- Itobayashi, E.
- Fukunishi, S.
- Ishikawa, T.
- Tajiri, K.
- Ochi, H.
- Toyoda, H.
- Ogawa, C.
- Nishimura, T.
- Hatanaka, T.
- Kakizaki, S.
- Shimada, N.
- Kawata, K.
- Naganuma, A.
- Kosaka, H.
- Matono, T.
- Kuroda, H.
- Yata, Y.
- Ohama, H.
- Tada, F.
- Nouso, K.
- Morishita, A.
- Tsutsui, A.
- Nagano, T.
- Itokawa, N.
- Okubo, T.
- Arai, T.
- Yokohama, K.
- Nishikawa, H.
- Imai, M.
- Koizumi, Y.
- Nakamura, S.
- Iijima, H.
- Kaibori, M.
- Hiasa, Y.
- Kumada, T.
- on Google Scholar
- Tanaka, K.
- Tsuji, K.
- Hiraoka, A.
- Tada, T.
- Hirooka, M.
- Kariyama, K.
- Tani, J.
- Atsukawa, M.
- Takaguchi, K.
- Itobayashi, E.
- Fukunishi, S.
- Ishikawa, T.
- Tajiri, K.
- Ochi, H.
- Toyoda, H.
- Ogawa, C.
- Nishimura, T.
- Hatanaka, T.
- Kakizaki, S.
- Shimada, N.
- Kawata, K.
- Naganuma, A.
- Kosaka, H.
- Matono, T.
- Kuroda, H.
- Yata, Y.
- Ohama, H.
- Tada, F.
- Nouso, K.
- Morishita, A.
- Tsutsui, A.
- Nagano, T.
- Itokawa, N.
- Okubo, T.
- Arai, T.
- Yokohama, K.
- Nishikawa, H.
- Imai, M.
- Koizumi, Y.
- Nakamura, S.
- Iijima, H.
- Kaibori, M.
- Hiasa, Y.
- Kumada, T.
- on PubMed
- Tanaka, K.
- Tsuji, K.
- Hiraoka, A.
- Tada, T.
- Hirooka, M.
- Kariyama, K.
- Tani, J.
- Atsukawa, M.
- Takaguchi, K.
- Itobayashi, E.
- Fukunishi, S.
- Ishikawa, T.
- Tajiri, K.
- Ochi, H.
- Toyoda, H.
- Ogawa, C.
- Nishimura, T.
- Hatanaka, T.
- Kakizaki, S.
- Shimada, N.
- Kawata, K.
- Naganuma, A.
- Kosaka, H.
- Matono, T.
- Kuroda, H.
- Yata, Y.
- Ohama, H.
- Tada, F.
- Nouso, K.
- Morishita, A.
- Tsutsui, A.
- Nagano, T.
- Itokawa, N.
- Okubo, T.
- Arai, T.
- Yokohama, K.
- Nishikawa, H.
- Imai, M.
- Koizumi, Y.
- Nakamura, S.
- Iijima, H.
- Kaibori, M.
- Hiasa, Y.
- Kumada, T.
Need Help?
Order Article Reprints
Journal: Cancers, 2023
Volume: 15
Number: 4348
4348
Article:
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
Authors:
by
Kazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hideko Ohama, Fujimasa Tada, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Keisuke Yokohama, Hiroki Nishikawa, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Hiroko Iijima, Masaki Kaibori, Yoichi Hiasa and Takashi Kumadaadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/15/17/4348
MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.
If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.
Cite
Tanaka, K.; Tsuji, K.; Hiraoka, A.; Tada, T.; Hirooka, M.; Kariyama, K.; Tani, J.; Atsukawa, M.; Takaguchi, K.; Itobayashi, E.; et al. Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers 2023, 15, 4348. https://doi.org/10.3390/cancers15174348
Tanaka K, Tsuji K, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, et al. Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers. 2023; 15(17):4348. https://doi.org/10.3390/cancers15174348
Chicago/Turabian StyleTanaka, Kazunari, Kunihiko Tsuji, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, and et al. 2023. "Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study" Cancers 15, no. 17: 4348. https://doi.org/10.3390/cancers15174348
APA StyleTanaka, K., Tsuji, K., Hiraoka, A., Tada, T., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Ishikawa, T., Tajiri, K., Ochi, H., Toyoda, H., Ogawa, C., Nishimura, T., Hatanaka, T., Kakizaki, S., ... Kumada, T., on behalf of the Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group. (2023). Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers, 15(17), 4348. https://doi.org/10.3390/cancers15174348
